apomorphine has been researched along with Dementia Praecox in 194 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 109 (56.19) | 18.7374 |
| 1990's | 30 (15.46) | 18.2507 |
| 2000's | 25 (12.89) | 29.6817 |
| 2010's | 24 (12.37) | 24.3611 |
| 2020's | 6 (3.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulrahim, HA; Aderibigbe, AO; Bakre, AG; Ben-Azu, B; Ezurike, PU; Isibor, H; Omeiza, NA; Sowunmi, AA | 1 |
| Cañete, T; Corda, MG; Fernández-Teruel, A; Giorgi, O; Oliveras, I; Río-Álamos, C; Sampedro-Viana, D; Tobeña, A | 1 |
| Alachkar, A; Civelli, O; Liang, X; Wang, C; Wang, L; Wang, Z; Zhang, X; Zhang, Y | 1 |
| Dravid, SM; Gakare, SG; Gawai, P; Sarode, L; Ugale, RR; Upadhyay, R | 1 |
| Gogos, A; Kusljic, S; Sbisa, A; van den Buuse, M; Zethoven, D | 1 |
| Checheto, T; Del-Bel, E; Issy, AC; Noël, F; Pedrazzi, JFC; Silva, RR; van Oosten, ABS | 1 |
| Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z | 1 |
| Pandy, V; Vijeepallam, K | 1 |
| Fujiwara, H; Higuchi, M; Ito, H; Kimura, Y; Kodaka, F; Kubota, M; Moriguchi, S; Nagashima, T; Okubo, Y; Suhara, T; Takahashi, H; Takahata, K; Takano, H | 1 |
| Christensen, KV; Christoffersen, CT; Clausen, D; Didriksen, M; Egebjerg, J; Fejgin, K; Kallunki, P; Larsen, PH; Lauridsen, JB; Mørk, A; Nielsen, J; Nielsen, V; Sotty, F; Werge, TM; Yavich, L | 1 |
| Frankle, WG; Himes, M; Mason, NS; Mathis, CA; Narendran, R; Paris, J | 1 |
| Gogos, A; Sbisa, A; van den Buuse, M | 1 |
| Antonio, CB; Betti, AH; da Rocha Pitta, I; do Rego, JC; do Rego, JL; Herzfeldt, V; Pitta, MGDR; Rates, SMK; Vaudry, D | 1 |
| Raju, AB; Suresh, P | 1 |
| Kilic, FS; Kulluk, D; Musmul, A | 1 |
| Gogos, A; van den Buuse, M | 1 |
| Lafioniatis, A; Orfanidou, MA; Papadopoulou, ES; Pitsikas, N | 1 |
| Fukada, M; Kawaguchi, Y; Mamiya, T; Nakayama, A; Yao, TP | 1 |
| Abdullahi, OI; Abolarin, M; Iniaghe, LO; Magaji, MG; Magaji, RA | 1 |
| Aznar, S; Blázquez, G; Cañete, T; Corda, MG; Fernández-Teruel, A; Gerbolés, C; Giorgi, O; González-Maeso, J; Oliveras, I; Piludu, MA; Río-Alamos, C; Sampedro-Viana, D; Sánchez-González, A; Tobeña, A | 1 |
| Grace, AA; Valenti, O | 1 |
| Martens, GJ; Van Loo, KM; Van Schijndel, JE; Van Zweeden, M | 1 |
| Ahmed, MR; Bychkov, E; Gurevich, EV | 1 |
| Arakawa, R; Farde, L; Halldin, C; Ito, H; Kodaka, F; Miyoshi, M; Nakayama, K; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H | 1 |
| Beason-Held, LL; Bhattacharjee, AK; Der, M; Gallardo, KA; Herscovitch, P; Liow, JS; Rapoport, JL; Rapoport, SI; Thambisetty, M; Umhau, JC | 1 |
| Barbosa Silva, R; Melo, LL; Satake, S; Yamada, K | 1 |
| Akhtar, M; Khanam, R; Mahmood, D; Pillai, KK | 1 |
| Atack, J; Cik, M; De Bruyn, M; Hendrickx, H; Langlois, X; Lavreysen, H; Macdonald, G; Megens, A; Peeters, L; te Riele, P; Vermeire, J; Wouters, R | 1 |
| Cantrup, R; Rajakumar, N; Rushlow, WJ; Sathanantham, K | 1 |
| Antonio, CB; Barreiro, EJ; Betti, AH; Fraga, CA; Neves, G; Noël, F; Pranke, MA; Rates, SM | 1 |
| Cools, AR; Ellenbroek, BA | 1 |
| van den Buuse, M | 1 |
| Bailey, P; Crocq, MA; Duval, F; Macher, JP; Mokrani, MC; Monreal, J; Valdebenito, M | 1 |
| Ellenbroek, B; Geyer, MA | 1 |
| Koch, M; Schwabe, K | 1 |
| Bondarenko, NA; Gudasheva, TA; Guzevatykh, LS; Ostrovskaya, RU; Retyunskaya, MV; Voronina, TA | 1 |
| Elmer, GI; Guard, H; Hercher, E; Sydnor, J; Vogel, MW | 1 |
| Henriques, JA; Meller, CA; Roesler, R; Schwartsmann, G | 1 |
| Hannesson, DK; Howland, JG; Phillips, AG | 1 |
| Cools, AR; Degen, SB; Ellenbroek, BA; Wiegant, VM | 1 |
| Coolen, MW; Cools, AR; De Strooper, B; Ellenbroek, BA; Martens, GJ; Pulford, DJ; Serneels, L; Van Bakel, NN; Van Loo, KM | 1 |
| Akhtar, M; Ali, A; Pillai, KK; Uma Devi, P; Vohora, D | 1 |
| Amorosi, A; De Fazio, P; De Fazio, S; De Sarro, G; Donato, G; Perrotta, I; Russo, E | 1 |
| Martens, GJ; van Loo, KM | 1 |
| Agam, G; Belmaker, RH; Bersudsky, Y; Kozlovsky, N; Shaldubina, A; Woodgett, JR | 1 |
| Dai, X; Lal, S; Montoya, A; Ng Ying Kin, NM; Schwartz, G; Thavundayil, JX | 1 |
| Angrist, B; Gershon, S; Rotrosen, J | 1 |
| Lee, T; Seeman, P | 1 |
| Lideman, RR; Mukhin, AG; Zlobina, GP | 1 |
| Snyder, SH | 1 |
| Berger, PA; Davis, KL; Hollister, LE | 1 |
| Fraser, S; Gelder, M; Kolakowska, T | 1 |
| Etienne, P; Guyda, H; Iskandar, HI; Lal, S; Nair, NP; Thavundayil, JX; Wood, PL | 1 |
| Brown, GM; Brown, PJ; Cleghorn, JM; Dermer, SW; Kaplan, RD; MacCrimmon, DJ; Mitton, J | 1 |
| Brown, GM; Brown, PJ; Cleghorn, JM; Kaplan, RD; Mitton, J | 2 |
| Lecrubier, Y; Puech, AJ; Simon, P | 1 |
| Wagner, HN | 1 |
| Ackenheil, M; Albus, M; May, G; Müller-Spahn, F; Naber, D; Welter, D; Zander, K | 1 |
| Kalinin, VV; Nemtsov, AV | 1 |
| Meltzer, HY | 1 |
| Gershon, S; Lautin, A; Rotrosen, J; Stanley, M; Wazer, D | 1 |
| Rebec, GV | 1 |
| Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Levy, MI; Mathé, AA; Mohs, RC; Trigos, G | 1 |
| Crow, TJ; Ferrier, IN; Johnstone, EC | 4 |
| Sternberg, DE | 1 |
| Bernardi, F; Corsini, GU; Gessa, GL; Marrosu, F | 1 |
| Arbuthnott, GW; Brown, S; Christie, JE; Whalley, LJ | 1 |
| Louden, D; Melville, GN; Wenger, T; Wray, SR | 1 |
| Garver, DL; Hirschowitz, J; Zemlan, FP | 3 |
| Garver, D; Hirschowitz, J; Hitzemann, B; Hitzemann, R; Zemlan, F | 1 |
| Bigelow, LB; Cutler, NR; Jeste, DV; Kleinman, JE; Rogol, A; Weinberger, DR; Wyatt, RJ; Zalcman, S | 1 |
| Davis, BM; Davis, KL; Horvath, TB; Johns, CA; Kendler, KS; Levy, MI; Mathe, AA; Mohs, RC; Trigos, G | 1 |
| Busch, D; Fang, VS; Fogg, L; Kolakowska, T; Lewine, R; Meltzer, HY; Robertson, A; Strahilevitz, M | 1 |
| Garver, D; Hirschowitz, J; Hitzemann, B; Hitzemann, R | 1 |
| Lewine, R; Meltzer, HY; Perline, R | 1 |
| Brown, GM; deFraites, EA; Gold, PW; Malas, KL; van Kammen, DP | 1 |
| Bloxham, CA; Cross, AJ; Ferrier, IN | 1 |
| Davis, JM; Schaffer, MH; Smith, RC; Tamminga, CA | 2 |
| Brown, GL; Docherty, JP; Langer, DH | 1 |
| Bernardi, F; Bocchetta, A; Corsini, GU; Del Zompo, M; Pitzalis, GF | 1 |
| Snider, SR | 1 |
| Anokhina, IP | 1 |
| Cutler, NR; Jeste, DV; Karoum, F; Wyatt, RJ | 1 |
| Markova, OF; Stoliarov, GV | 1 |
| Schiff, SR | 1 |
| Busch, D; Fang, VS; Meltzer, HY | 1 |
| Stevens, JR | 1 |
| Dolan, RJ; Fletcher, P; Frackowiak, RS; Friston, KJ; Frith, CD; Grasby, PM | 1 |
| Awouters, FH; Janssen, PA | 1 |
| Caine, SB; Geyer, MA; Swerdlow, NR | 1 |
| Brambilla, F; Fassone, G; Marini, S; Nerozzi, D; Pancheri, P; Picardi, A; Saito, A | 1 |
| Bailey, P; Castro, JO; Crocq, MA; Duval, F; Lataste, X; Macher, JP; Mokrani, MC | 1 |
| Chakos, M; Cooper, T; Kane, J; Kronig, M; Lieberman, J; Munne, R; Pollack, S; Safferman, A; Szymanski, S; Umbricht, D | 1 |
| Cooper, T; Howard, A; Kane, JM; Kronig, MH; Lieberman, JA; Masiar, SJ; Novacenko, H; Pollack, S; Safferman, AZ; Szymanski, S | 1 |
| Maes, M; Meltzer, HY; Thompson, PA | 1 |
| LeDuc, PA; Mittleman, G; Whishaw, IQ | 1 |
| Alvir, J; Geisler, SH; Gonzalez, A; Jody, D; Lerner, G; Levy, DL; Mayerhoff, DI; Robinson, D; Smith, M; Szymanski, SR | 1 |
| Glenthøj, B; Hemmingsen, R; Holm, S; Laursen, H; Mogensen, J | 1 |
| Alvir, JM; Ashtari, M; Bogerts, B; Cooper, T; Degreef, G; Jody, D; Levy, DL; Lieberman, JA; Mayerhoff, DI | 1 |
| Bailey, PE; Crocq, MA; Duval, F; Macher, JP; Mokrani, MC | 1 |
| Corbett, R; Kafka, SH | 1 |
| Randall, PK; Wilcox, RE; Young, KA | 1 |
| Dolan, RJ; Fletcher, PC; Friston, KJ; Frith, CD; Grasby, PM | 1 |
| Brunner, J; Gattaz, WF | 1 |
| Cataneo, EA; Leiguarda, R; Manes, F; Merello, M; Petracca, G; Starkstein, S | 1 |
| Lipska, BK; Weinberger, DR | 1 |
| Feifel, D; Reza, T | 1 |
| Broersen, LM; Feldon, J; Weiner, I | 1 |
| Geyer, MA; Halim, ND; Martinez, ZA; Oostwegel, JL; Swerdlow, NR | 1 |
| Heijnen, CJ | 1 |
| Boksa, P; Vaillancourt, C | 1 |
| Jayathilake, K; Lee, MA; Meltzer, HY | 1 |
| Bauer, M; Heinz, A; Nolte-Zenker, B; Patzer, J; Schmidt, K; Schmidt, LG | 1 |
| Dépatie, L; Lal, S | 1 |
| Hsieh, Y; Wang, HC | 1 |
| Watson, S; Young, AM | 1 |
| Mattsson, A; Ogren, SO; Olson, L | 1 |
| Cianchetti, C; Corsini, GU; Del Zompo, M; Gessa, GL; Manconi, S; Mangoni, A | 1 |
| Seeman, P | 1 |
| Casper, RC; Davis, JM; Dekirmenjian, H; Garver, DL; Pandey, GN | 1 |
| Billingsley, ML; Goldstein, JM; Kubena, RK; Malick, JB | 1 |
| Beckmann, H | 1 |
| Davis, LG; Ehrlich, YH; Volavka, J | 1 |
| Fang, VS; Goode, DJ; Meltzer, HY; Schyve, P; Young, M | 1 |
| Davis, JM; Smith, RC; Tamminga, C | 1 |
| Cervantes, P; Guyda, H; Lal, S; Nair, NP; Pulman, J | 1 |
| Cervantes, P; Guyda, H; Lal, S; Nair, NP; Yassa, R | 1 |
| Angrist, B; Branchey, L; Gershon, S; Halpern, F; Oleshansky, M; Paquin, J; Rotrosen, J; Sachar, EJ | 1 |
| Angrist, B; Paquin, J; Rotrosen, J | 1 |
| Angrist, B; Clark, C; Gershon, S; Halpers, FS; Rotrosen, J; Sachar, EJ | 1 |
| Farley, IJ; Hornykeiwicz, O; Lee, T; Seeman, P; Tourtellotte, WW | 1 |
| Barry, VC; Klawans, HL | 1 |
| Angrist, BM; Gershon, S; Halpern, FS; Rotrosen, J; Sachar, EJ | 2 |
| Cervantes, P; Guyda, H; Lal, S; Smith, F | 1 |
| Ali, SI; Davis, JM; Ericksen, S; Garver, DL; Pandey, GN; Tamminga, C | 1 |
| Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC | 1 |
| Corsini, GU; Del Zompo, M; Manconi, S; Mangoni, A; Onali, PL; Piccardi, MP | 1 |
| Bunney, WE | 1 |
| Davis, JM; Frohman, LA; Pandey, G; Smith, RC; Tamminga, CA | 1 |
| Cervantes, P; Ettigi, P; Guyda, H; Lal, S; Nair, NP | 1 |
| De la Vega, CE; Lal, S | 1 |
| Baldessarini, RJ | 1 |
| Klawans, HL; Margolin, DI | 1 |
| Angrist, B; Gershon, S; Shopsin, B; Thompson, H | 1 |
| Luchins, D | 1 |
| Ansseau, M; Carvelli, T; Franchimont, P; Gazzotti, C; Legros, JJ; Timsit-Berthier, M; von Frenckell, R | 1 |
| Alvir, JM; Ashtari, M; Bilder, RM; Bogerts, B; Degreef, G; Geisler, SH; Lieberman, JA; Loebel, A; Mayerhoff, DI; Woerner, M | 1 |
| Murthy, NV; Wray, SR; Young, LE | 1 |
| Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S | 1 |
| Czachura, JF; Howbert, JJ; Rasmussen, K; Stockton, ME | 1 |
| Behrens, S; De Vry, J; Gattaz, WF; Häfner, H | 1 |
| Brown, GM; Cleghorn, JM; Franco, S; Garnett, ES; Kaplan, RD; Nahmias, C; Szechtman, B; Szechtman, H | 1 |
| Paternostro, JM | 1 |
| Braff, DL; Geyer, MA; Keith, VA; Swerdlow, NR | 1 |
| Davidson, M; Davis, BM; Davis, KL; Losonczy, MF; Mathé, AA; Mohs, RC; Song, IS | 1 |
| Ackenheil, M; Hippius, H; Müller-Spahn, F | 1 |
| Bunney, BS; Chiodo, LA; Freeman, AS | 1 |
| Davis, JM; Schaffer, MH; Tamminga, CA | 1 |
| Garver, DL; Hirschowitz, J; Hitzemann, RJ; Zemlan, FP | 1 |
| Hietala, J; Huupponen, R; Pihlajamäki, K; Säkö, E; Scheinin, M; Seppälä, OP; Syvälahti, EK | 1 |
| Carnoy, P; Puech, AJ; Simon, P; Soubrie, P | 1 |
| Alphs, LD; Foster, NL; Gotts, MD; Tamminga, CA; Thaker, GK | 1 |
| Garver, DL; Hirschowitz, J; Sautter, F; Zemlan, FP | 2 |
| Hollister, LE | 1 |
| Garver, DL | 2 |
| Kazawa, T | 1 |
| Bowden, CL; Contreras, SA; Maas, JW; Seleshi, E | 1 |
| Brown, GM; Brown, PJ; Cleghorn, JM; Kaplan, RD; Mitton, J; Szechtman, B; Szechtman, H | 1 |
| Hietala, J; Pihlajamäki, K; Säkö, E; Scheinin, M; Syvälahti, EK | 1 |
| Brown, GM; de Fraites, EA; Gold, PW; Malas, KL; van Kammen, DP | 1 |
| Fleischmann, RL; Garver, DL; Hirschowitz, J; Hitzemann, RJ; Zemlan, FP | 1 |
| Bocchetta, A; Corsini, GU; Del Zompo, M; Piccardi, MP | 1 |
| Davidson, M; Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Mohs, RC | 1 |
| Hietala, J; Koulu, M; Scheinin, M; Syvälahti, E | 1 |
| Davis, BM; Davis, KL; Horvath, TB; Johns, CA; Levy, MI; Mathé, AA; Mohs, RC; Rothpearl, AB | 1 |
| Fields, R; Peters, J; Rosen, J; van Kammen, DP; van Kammen, WB | 1 |
| Gessa, GL; Gessa, R; Tagliamonte, A | 1 |
| Lipton, MA | 1 |
| Fuxe, K; Nyström, M; Ogren, SO; Smith, R; Tovi, M | 1 |
| Munkvad, I; Randrup, A | 1 |
| Stille, G | 2 |
| Soyka, D | 1 |
19 review(s) available for apomorphine and Dementia Praecox
| Article | Year |
|---|---|
Apomorphine susceptibility and animal models for psychopathology: genes and environment.
Topics: Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Environment; Genetic Predisposition to Disease; Genetics, Behavioral; Rats; Rats, Inbred Strains; Schizophrenia; Species Specificity; Stereotyped Behavior | 2002 |
Animal behavior models of the mechanisms underlying antipsychotic atypicality.
Topics: Animals; Antipsychotic Agents; Apomorphine; Auditory Perception; Avoidance Learning; Conditioning, Psychological; Humans; Hyperkinesis; Learning; Models, Animal; Neural Inhibition; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia; Social Isolation | 2003 |
[Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Topics: Adenylyl Cyclase Inhibitors; Animals; Antipsychotic Agents; Apomorphine; Blood Platelets; Brain; Bromocriptine; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Humans; Methyltyrosines; Rats; Receptors, Dopamine; Receptors, Opioid; Schizophrenia; Synaptic Membranes; Synaptic Transmission | 1980 |
[Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
Topics: Antipsychotic Agents; Apomorphine; Cyclic AMP; Drug Evaluation; Electroencephalography; Evoked Potentials; Galvanic Skin Response; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Monoamine Oxidase; Prognosis; Schizophrenia; Sleep Stages | 1981 |
Dopamine autoreceptor stimulation: clinical significance.
Topics: Apomorphine; Dopamine; Haloperidol; Humans; Huntington Disease; Mental Disorders; Neurons; Parkinson Disease; Piribedil; Receptors, Dopamine; Relaxation; Schizophrenia; Sleep; Tourette Syndrome | 1982 |
Biologic tests in psychiatry.
Topics: Anxiety Disorders; Apomorphine; Clonidine; Dexamethasone; Dextroamphetamine; Growth Hormone; Humans; Hydrocortisone; Imipramine; Lactates; Mental Disorders; Mood Disorders; Panic; Prognosis; Schizophrenia; Serotonin; Thyrotropin-Releasing Hormone | 1984 |
Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response.
Topics: Adult; Apomorphine; Blood; Blood Platelets; Female; Growth Hormone; Humans; Male; Manuals as Topic; Monoamine Oxidase; Psychotic Disorders; Schizophrenia; Serotonin | 1982 |
Dopamine receptor supersensitivity and schizophrenia: a review.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Apomorphine; Brain Chemistry; Dopamine; Female; Guinea Pigs; Humans; Life Change Events; Neurons; Pregnancy; Pregnancy Complications; Prolactin; Rats; Receptors, Dopamine; Schizophrenia | 1981 |
Cerebellar pathology in schizophrenia--cause or consequence?
Topics: Animals; Apomorphine; Atrophy; Behavior, Animal; Brain Stem; Cats; Cerebellar Diseases; Cerebellum; Dopamine; Haloperidol; Humans; Hypothalamus; Limbic System; Locus Coeruleus; Motor Activity; Neural Pathways; Rats; Schizophrenia | 1982 |
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
Topics: Apomorphine; Brain; Dopamine; Humans; Parkinson Disease; Receptors, Dopamine; Schizophrenia | 2001 |
Anti-schizophrenic drugs--membrane receptor sites of action.
Topics: Adenylyl Cyclases; Antipsychotic Agents; Apomorphine; Binding Sites; Humans; Membranes; Neural Conduction; Neurotransmitter Agents; Osmolar Concentration; Receptors, Dopamine; Receptors, Drug; Schizophrenia; Stereoisomerism; Synapses | 1977 |
Effect of apomorphine on schizophrenic symptoms.
Topics: Apomorphine; Chronic Disease; Humans; Schizophrenia | 1977 |
On the role of dopamine in the pathophysiology of anorexia nervosa.
Topics: 17-Ketosteroids; Amphetamine; Anorexia Nervosa; Apomorphine; Compulsive Personality Disorder; Dopamine; Female; Glucose Tolerance Test; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Movement Disorders; Parkinson Disease; Schizophrenia; Steroids; Thinness | 1976 |
Biological transmethylation involving S-adenosylmethionine: development of assay methods and implications for neuropsychiatry.
Topics: Acetylserotonin O-Methyltransferase; Animals; Apomorphine; Blood Platelets; Brain; Histamine; Humans; Leukemia; Levodopa; Methionine; Methionine Adenosyltransferase; Methyltransferases; Monoamine Oxidase Inhibitors; Pyrogallol; Rabbits; Rats; S-Adenosylmethionine; Schizophrenia; Serotonin; Tetrahydrofolates | 1975 |
Neuroendocrinological and biochemical effects of chronic neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Apomorphine; beta-Endorphin; Drug Tolerance; Endocrine System Diseases; Endorphins; Female; Genetic Variation; Homovanillic Acid; Humans; Hydrocortisone; Hypothalamus; Luteinizing Hormone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nervous System Diseases; Norepinephrine; Prolactin; Receptors, Adrenergic, alpha; Receptors, Dopamine; Schizophrenia; Thyrotropin | 1985 |
The two-syndrome concept and neuroendocrinology of schizophrenia.
Topics: Antipsychotic Agents; Apomorphine; Brain; Brain Chemistry; Cognition; Dopamine; Follicle Stimulating Hormone; Growth Hormone; Hormones; Humans; Luteinizing Hormone; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia | 1986 |
Neuroendocrine findings in the schizophrenias.
Topics: Antipsychotic Agents; Apomorphine; Clonidine; Dexamethasone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hydrocortisone; Neurosecretory Systems; Prolactin; Schizophrenia; Thyrotropin-Releasing Hormone | 1988 |
Neuroendocrine findings in the schizophrenias.
Topics: Apomorphine; Clonidine; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Schizophrenia; Thyrotropin | 1988 |
Pharmacology and physiology of stereotyped behavior.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior; Behavior, Animal; Bipolar Disorder; Brain; Conditioning, Operant; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Grooming; Haplorhini; Humans; Psychoses, Substance-Induced; Rats; Schizophrenia; Stereotyped Behavior; Tranquilizing Agents | 1974 |
28 trial(s) available for apomorphine and Dementia Praecox
| Article | Year |
|---|---|
Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
Topics: Adult; Apomorphine; Brain; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ligands; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Risperidone; Schizophrenia; Young Adult | 2011 |
The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.
Topics: Adult; Apomorphine; Arachidonic Acid; Brain; Carbon Isotopes; Cerebrovascular Circulation; Dopamine Agonists; Dopaminergic Neurons; Functional Laterality; Group IV Phospholipases A2; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Potassium; Radiography; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Synaptic Transmission | 2012 |
Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
Topics: Adrenocorticotropic Hormone; Adult; Apomorphine; Brief Psychiatric Rating Scale; Diagnosis, Differential; Dopamine; Dopamine Agonists; Female; Fenfluramine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Prolactin; Schizophrenia; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenic Psychology; Serotonin; Serotonin Agents | 2003 |
Induction of tolerance of dopaminergic responses in man.
Topics: Adolescent; Adult; Apomorphine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Drug Tolerance; Human Growth Hormone; Humans; Hydrocortisone; Hypnotics and Sedatives; Male; Middle Aged; Prolactin; Schizophrenia; Sleep Stages; Yawning | 2008 |
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
Topics: Adult; Apomorphine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Growth Hormone; Homovanillic Acid; Humans; Male; Placebos; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1984 |
Clinical effects of apomorphine in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety; Apomorphine; Blinking; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Schizophrenia | 1984 |
Apomorphine and schizophrenia.
Topics: Adult; Apomorphine; Dyskinesia, Drug-Induced; Homovanillic Acid; Hormones; Humans; Male; Middle Aged; Schizophrenia | 1984 |
Apomorphine reduces schizophrenic symptoms.
Topics: Apomorphine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Schizophrenia | 1980 |
The use of dopamine agonists in the treatment of schizophrenia.
Topics: Adolescent; Adult; Apomorphine; Clinical Trials as Topic; Dopamine; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1981 |
Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patients.
Topics: Adult; Apomorphine; Female; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Male; Phenylacetates; Schizophrenia; Time Factors | 1982 |
Noradrenergic and dopaminergic interrelation in schizophrenia.
Topics: Adolescent; Adult; Apomorphine; Arousal; Chronic Disease; Clonidine; Dopamine; Growth Hormone; Humans; Male; Norepinephrine; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Ergolines; Female; Growth Hormone; Humans; Male; Neurosecretory Systems; Piperazines; Prolactin; Quinolones; Schizophrenia; Sulpiride | 1993 |
Effect of the placebo control condition in neuroendocrine challenge studies.
Topics: 5-Hydroxytryptophan; Antipsychotic Agents; Apomorphine; Bias; Buspirone; Data Interpretation, Statistical; Depressive Disorder; Female; Fenfluramine; Growth Hormone; Humans; Hydrocortisone; Male; Prolactin; Pyrazines; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists | 1994 |
Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls.
Topics: Adult; Apomorphine; Brain; Dopamine; Female; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission; Thinking | 1993 |
Multihormonal responses to apomorphine in mental illness.
Topics: Adrenocorticotropic Hormone; Adult; Apomorphine; Depression; Dopamine Agonists; Female; Growth Hormone; Humans; Hydrocortisone; Injections, Subcutaneous; Male; Mental Disorders; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Thyrotropin | 1995 |
Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia.
Topics: Acute Disease; Adult; Apomorphine; Conditioning, Psychological; Dopamine; Frontal Lobe; Humans; Schizophrenia; Temporal Lobe; Tomography, Emission-Computed; Verbal Behavior | 1996 |
Drug-induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-Dopa and apomorphine.
Topics: Adult; Analysis of Variance; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Cross-Over Studies; Double-Blind Method; Female; Humans; Levodopa; Motor Activity; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Schizophrenia | 1996 |
The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
Topics: Adrenocorticotropic Hormone; Adult; Antipsychotic Agents; Apomorphine; Brief Psychiatric Rating Scale; Dopamine; Dopamine Agonists; Female; Growth Hormone; Humans; Hydrocortisone; Male; Prolactin; Receptors, Dopamine; Schizophrenia | 2001 |
Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
Topics: Adult; Affect; Alcoholism; Apomorphine; Corticotropin-Releasing Hormone; Depressive Disorder; Dopamine Agonists; Female; Hormones; Humans; Male; Middle Aged; Motivation; Opioid-Related Disorders; Psychomotor Performance; Reaction Time; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 2001 |
Schizophrenic symptoms improve with apomorphine.
Topics: Apomorphine; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nerve Endings; Receptors, Dopamine; Schizophrenia | 1978 |
Apomorphine and psychopathology.
Topics: Alcoholism; Antidepressive Agents; Apomorphine; Bipolar Disorder; Clinical Trials as Topic; Depression; Humans; Libido; Male; Middle Aged; Penis; Placebos; Psychiatric Status Rating Scales; Psychomotor Disorders; Psychoses, Substance-Induced; Schizophrenia | 1975 |
Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital.
Topics: Adolescent; Adult; Analysis of Variance; Apomorphine; Brain; Female; Fluphenazine; Follow-Up Studies; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Prognosis; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1992 |
Apomorphine's antipsychotic activity.
Topics: Antipsychotic Agents; Apomorphine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1985 |
Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.
Topics: Administration, Oral; Adult; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Humans; Placebos; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1986 |
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; Dopamine; Double-Blind Method; Female; Haloperidol; Homovanillic Acid; Humans; Loxapine; Male; Random Allocation; Schizophrenia | 1988 |
Effects of intravenous and subcutaneous administration of apomorphine on the clinical symptoms of chronic schizophrenics.
Topics: Adult; Apomorphine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Schizophrenia; Schizophrenic Psychology | 1986 |
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
Topics: Acute Disease; Adult; Age Factors; Apomorphine; Carbidopa; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Research Design; Schizophrenia; Schizophrenic Psychology; Sodium Chloride | 1985 |
[The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus].
Topics: Amitriptyline; Apomorphine; Aporphines; Barbiturates; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Diazepam; Dimenhydrinate; Eye Movements; Fluphenazine; Haloperidol; Humans; Imipramine; Schizophrenia; Thioridazine; Triflupromazine | 1968 |
147 other study(ies) available for apomorphine and Dementia Praecox
| Article | Year |
|---|---|
Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Ethanol; Ketamine; Male; Mice; Plant Extracts; Psychotic Disorders; Schizophrenia | 2022 |
Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia- related Symptoms.
Topics: Animals; Apomorphine; Disease Models, Animal; Dopamine; Prepulse Inhibition; Rats; Rats, Brattleboro; Reflex, Startle; Schizophrenia | 2023 |
A Natural Product with High Affinity to Sigma and 5-HT
Topics: Animals; Antipsychotic Agents; Apomorphine; Dizocilpine Maleate; Isoquinolines; Male; Mice; Motor Activity; Receptors, Histamine H2; Receptors, Serotonin; Receptors, sigma; Schizophrenia; Sigma-1 Receptor | 2019 |
Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Dizocilpine Maleate; Male; Maze Learning; Mice; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Social Interaction; Stereoisomerism; Stereotyped Behavior | 2020 |
The effect of 17β-estradiol on maternal immune activation-induced changes in prepulse inhibition and dopamine receptor and transporter binding in female rats.
Topics: Animals; Apomorphine; Dopamine Agonists; Estradiol; Female; Pregnancy; Prepulse Inhibition; Rats; Receptors, Dopamine D1; Reflex, Startle; Schizophrenia | 2020 |
Effects of Doxycycline in Swiss Mice Predictive Models of Schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Anti-Bacterial Agents; Apomorphine; Dopamine Agonists; Dopamine Antagonists; Doxycycline; Forecasting; Male; Mice; Prepulse Inhibition; Receptors, Dopamine; Schizophrenia | 2020 |
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Enzyme Inhibitors; Haloperidol; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Schizophrenia | 2021 |
Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Male; Methantheline; Mice, Inbred ICR; Morinda; Phytotherapy; Quaternary Ammonium Compounds; Rutin; Schizophrenia; Schizophrenic Psychology; Scopoletin; Stair Climbing; Stereotyped Behavior | 2017 |
Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
Topics: Adult; Antipsychotic Agents; Apomorphine; Brain Mapping; Corpus Striatum; Female; Humans; Male; Positron-Emission Tomography; Raclopride; Radioligand Assay; Radiopharmaceuticals; Receptors, Dopamine D2; Schizophrenia; Statistics as Topic; Young Adult | 2017 |
A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.
Topics: Abnormalities, Multiple; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Chromosome Deletion; Chromosomes, Human, Pair 1; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Excitatory Amino Acid Antagonists; Megalencephaly; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Phencyclidine; Phenotype; Prepulse Inhibition; Quinpirole; Receptors, Dopamine; Schizophrenia; Ventral Tegmental Area | 2017 |
Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
Topics: Adolescent; Adult; Amphetamine; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Female; Humans; Male; Positron-Emission Tomography; Radioactive Tracers; Schizophrenia; Young Adult | 2018 |
The effect of estrogenic compounds on psychosis-like behaviour in female rats.
Topics: Animals; Apomorphine; Dopamine Agonists; Estradiol; Estrogens; Female; Ovariectomy; Psychotic Disorders; Raloxifene Hydrochloride; Rats; Rats, Long-Evans; Receptors, Dopamine; Schizophrenia; Selective Estrogen Receptor Modulators; Tamoxifen | 2018 |
PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Cognition; Disease Models, Animal; Dopamine Agonists; Imidazolidines; Male; Memory; Memory Disorders; Memory, Long-Term; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Receptors, Adrenergic; Schizophrenia; Schizophrenic Psychology | 2019 |
Antidopaminergic effects of leucine and genistein on shizophrenic rat models.
Topics: Aggression; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopaminergic Neurons; Genistein; Leucine; Motor Activity; Protein Kinase Inhibitors; Rats; Rats, Wistar; Schizophrenia; Stereotyped Behavior | 2013 |
Effects of dehydroepiandrosterone in amphetamine-induced schizophrenia models in mice.
Topics: Adjuvants, Immunologic; Amphetamine; Animals; Apomorphine; Catalepsy; Central Nervous System Stimulants; Dehydroepiandrosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Locomotion; Mice; Schizophrenia; Statistics, Nonparametric; Time Factors | 2014 |
Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Topics: Acoustic Stimulation; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Ovariectomy; Prepulse Inhibition; Raloxifene Hydrochloride; Random Allocation; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle; Schizophrenia; Selective Estrogen Receptor Modulators; Tamoxifen | 2015 |
Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Enzyme Inhibitors; Guanidines; Ketamine; Male; Nitric Oxide Synthase Type II; Random Allocation; Rats, Wistar; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2016 |
Dopaminergic abnormalities in Hdac6-deficient mice.
Topics: Animals; Apomorphine; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Dopaminergic Neurons; Histone Deacetylase 6; Male; Methamphetamine; Mice, 129 Strain; Mice, Knockout; Motor Activity; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Schizophrenia | 2016 |
Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Anxiety; Apomorphine; Behavior, Animal; Caloric Restriction; Exploratory Behavior; Female; Grooming; Male; Mice; Resveratrol; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior; Stilbenes; Swimming | 2017 |
Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Topics: Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Clozapine; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Locomotion; Male; Prepulse Inhibition; Rats; Receptor, Serotonin, 5-HT2A; Reflex, Startle; Schizophrenia; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists | 2017 |
Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.
Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Electrophysiological Phenomena; Imidazoles; Indoles; Male; Neural Pathways; Neurons; Nucleus Accumbens; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Mitogen; Schizophrenia; Signal Transduction; Ventral Tegmental Area | 2010 |
Gene expression profiling in brain regions of a rat model displaying schizophrenia-related features.
Topics: Animals; Apomorphine; Brain; Disease Models, Animal; Gene Expression Profiling; Kv Channel-Interacting Proteins; Male; Membrane Proteins; Microarray Analysis; Phenotype; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Species Specificity | 2010 |
Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.
Topics: Animals; Animals, Newborn; Apomorphine; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; G-Protein-Coupled Receptor Kinases; HEK293 Cells; Hippocampus; Humans; Male; Mitogen-Activated Protein Kinase 3; Motor Activity; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Schizophrenia; Sex Characteristics; Signal Transduction | 2011 |
Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on prepulse inhibition of the acoustic startle reflex in rat.
Topics: Acoustic Stimulation; Animals; Apomorphine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Inferior Colliculi; Male; Microinjections; Rats; Rats, Wistar; Receptors, Dopamine D2; Reflex, Startle; Schizophrenia | 2012 |
Reversal of oxidative stress by histamine H₃ receptor-ligands in experimental models of schizophrenia.
Topics: Amphetamine; Animals; Antioxidants; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain Chemistry; Catalase; Catalepsy; Central Nervous System Stimulants; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutathione; Haloperidol; Histamine H3 Antagonists; Male; Mice; Motor Activity; Oxidative Stress; Rats; Schizophrenia; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |
Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Brain; Catalepsy; Cells, Cultured; CHO Cells; Cricetinae; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Ligands; Locomotion; Male; Olanzapine; Piperidines; Prolactin; Pyridazines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D2; Schizophrenia; Serotonin | 2012 |
Chronic hyperdopaminergic activity of schizophrenia is associated with increased ΔFosB levels and cdk-5 signaling in the nucleus accumbens.
Topics: Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Blotting, Western; Chronic Disease; Cyclin-Dependent Kinase 5; Dopamine; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Hyperkinesis; Immunohistochemistry; Motor Activity; Nucleus Accumbens; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Schizophrenia; Stress, Psychological; Tissue Fixation | 2012 |
New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Barbiturates; Catalepsy; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Hypothermia; Ketamine; Male; Mice; Motor Activity; Piperazines; Psychoacoustics; Reflex, Startle; Schizophrenia; Sleep | 2013 |
Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats.
Topics: Acoustic Stimulation; Amphetamine; Animals; Anxiety; Apomorphine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Maze Learning; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reflex, Startle; Schizophrenia; Species Specificity | 2003 |
Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats.
Topics: Animals; Apomorphine; Denervation; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Ibotenic Acid; Male; Neural Inhibition; Neural Pathways; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia; Synaptic Transmission | 2004 |
Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Ketamine; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Proline; Schizophrenia; Tyrosine | 2003 |
Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.
Topics: Animals; Antineoplastic Agents; Apomorphine; Brain; Cytarabine; Disease Models, Animal; Dopamine Agonists; Drug Interactions; Female; Hallucinogens; Male; Maternal-Fetal Exchange; Phencyclidine; Pregnancy; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2004 |
The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice.
Topics: Animals; Antineoplastic Agents; Apomorphine; Bombesin; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Mice; Peptide Fragments; Receptors, Bombesin; Schizophrenia | 2004 |
Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats.
Topics: Acoustic Stimulation; Age Factors; Amphetamine; Animals; Animals, Newborn; Apomorphine; Behavior, Animal; Cerebral Cortex; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Exploratory Behavior; Female; Hippocampus; Inhibition, Psychological; Kainic Acid; Limbic System; Male; Maze Learning; Motor Activity; Pregnancy; Rats; Rats, Long-Evans; Reaction Time; Reflex, Startle; Schizophrenia | 2004 |
The development of various somatic markers is retarded in an animal model for schizophrenia, namely apomorphine-susceptible rats.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Biomarkers; Disease Models, Animal; Dopamine Agonists; Female; Genotype; Handling, Psychological; Male; Phenotype; Rats; Rats, Inbred Strains; Schizophrenia; Species Specificity; Stereotyped Behavior; Stress, Psychological | 2005 |
Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders.
Topics: Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; Apomorphine; Aspartic Acid Endopeptidases; Base Sequence; Behavior, Animal; Blotting, Northern; Blotting, Western; Disease Models, Animal; Endopeptidases; Exons; Gene Dosage; Genetic Predisposition to Disease; Genotype; Humans; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Peptide Hydrolases; Phenotype; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Species Specificity; Stereotyped Behavior | 2005 |
Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Histamine Agonists; Histamine Antagonists; Methylhistamines; Mice; Models, Animal; Motor Activity; Piperidines; Receptors, Histamine H3; Schizophrenia; Stereotyped Behavior; Time Factors | 2006 |
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus.
Topics: Animals; Apomorphine; Disease Models, Animal; Dopamine; Gerbillinae; Hippocampus; Humans; Microscopy, Electron, Scanning; Nerve Degeneration; Neurons; Schizophrenia | 2007 |
Identification of genetic and epigenetic variations in a rat model for neurodevelopmental disorders.
Topics: Animals; Apomorphine; Base Sequence; Chromosome Mapping; Chromosomes, Human, Pair 9; Disease Models, Animal; DNA Primers; Gene Rearrangement; Genetic Predisposition to Disease; Genetic Variation; Humans; Membrane Proteins; Mental Disorders; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Rats; Rats, Wistar; Schizophrenia | 2007 |
Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
Topics: Animals; Apomorphine; Autopsy; Behavior, Animal; Brain; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Compounds; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenotype; Reflex, Startle; Schizophrenia; Stereotyped Behavior; Swimming | 2008 |
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.
Topics: Adult; Amphetamine; Antipsychotic Agents; Apomorphine; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Vomiting | 1980 |
Abnormal neuroleptic/dopamine receptors in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Brain; Caudate Nucleus; Haloperidol; Humans; Middle Aged; Nucleus Accumbens; Receptors, Dopamine; Schizophrenia; Spiperone | 1980 |
Dopamine receptors, neuroleptics, and schizophrenia.
Topics: Adenylyl Cyclases; Antipsychotic Agents; Apomorphine; Brain; Brain Chemistry; Caudate Nucleus; Dopamine; Guanosine Triphosphate; Haloperidol; Humans; Nucleus Accumbens; Radioligand Assay; Receptors, Dopamine; Schizophrenia; Spiperone | 1981 |
Apomorphine in schizophrenia.
Topics: Antipsychotic Agents; Apomorphine; Double-Blind Method; Drug Synergism; Humans; Schizophrenia | 1980 |
Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
Topics: Adult; Antipsychotic Agents; Apomorphine; Female; Growth Hormone; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Sleep Stages | 1981 |
Drug-induced growth hormone and prolactin responses in schizophrenia research.
Topics: Antipsychotic Agents; Apomorphine; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Neurotransmitter Agents; Prolactin; Receptors, Dopamine; Receptors, Histamine H2; Research; Schizophrenia | 1982 |
Growth hormone responses to apomorphine HCl in schizophrenic patients on drug holidays and at relapse.
Topics: Adult; Antipsychotic Agents; Apomorphine; Dose-Response Relationship, Drug; Female; Growth Hormone; Humans; Longitudinal Studies; Male; Recurrence; Schizophrenia | 1983 |
Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Apomorphine; Dose-Response Relationship, Drug; Growth Hormone; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology | 1983 |
Pharmacological classification of benzamides.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Brain; Dopamine Antagonists; Hallucinations; Humans; Receptors, Dopamine; Schizophrenia | 1984 |
Imaging CNS receptors: the dopaminergic system.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose; Dyskinesia, Drug-Induced; Fluorine; Haloperidol; Humans; Parkinson Disease; Radioisotopes; Receptors, Dopamine; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1984 |
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prolactin; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Time Factors | 1984 |
Discrimination of functionally heterogeneous receptor subpopulations: antipsychotic and antidopaminergic properties of metoclopramide [proceedings].
Topics: Animals; Apomorphine; Binding Sites; Humans; Metoclopramide; Rats; Receptors, Dopamine; Receptors, Neurotransmitter; Schizophrenia; Spiperone | 1981 |
Cholecystokinin (CCK): ascension from gut to brain.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Bucladesine; Ceruletide; Cholecystokinin; Chronic Disease; Dopamine; Humans; Rats; Rats, Inbred Strains; Schizophrenia; Species Specificity | 1983 |
Auto- and postsynaptic dopamine receptors in the central nervous system.
Topics: Animals; Apomorphine; Central Nervous System; Corpus Striatum; Dopamine Antagonists; Humans; Parkinson Disease; Rats; Receptors, Dopamine; Schizophrenia; Substantia Nigra; Synaptic Transmission | 1984 |
Neuropsychiatric implications of drugs acting on dopamine receptors: the effect of apomorphine.
Topics: Animals; Apomorphine; Bipolar Disorder; Blood-Brain Barrier; Electroencephalography; Humans; Huntington Disease; Motor Activity; Parkinson Disease; Rats; Receptors, Dopamine; Schizophrenia; Sleep | 1980 |
Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine.
Topics: Acute Disease; Adult; Apomorphine; Dopamine; Female; Growth Hormone; Humans; Male; Prolactin; Schizophrenia; Schizophrenic Psychology; Stimulation, Chemical | 1984 |
Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
Topics: Animals; Apomorphine; Dextroamphetamine; Dopamine Antagonists; Humans; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Schizophrenia; Septal Nuclei | 1984 |
Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapy.
Topics: Apomorphine; Bipolar Disorder; Growth Hormone; Humans; Lithium; Psychotic Disorders; Schizophrenia; Time Factors | 1984 |
On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
Topics: Adult; Apomorphine; Blood Platelets; Female; Growth Hormone; Humans; Male; Monoamine Oxidase; Schizophrenia | 1983 |
Apomorphine response and subtyping of schizophrenia.
Topics: Adult; Apomorphine; Cerebral Ventricles; Chronic Disease; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1983 |
Longitudinal instability of hormone responses in schizophrenia.
Topics: Adult; Apomorphine; Female; Growth Hormone; Humans; Longitudinal Studies; Male; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Recurrence; Schizophrenia; Schizophrenic Psychology | 1983 |
Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Apomorphine; Delusions; Depressive Disorder; Female; Growth Hormone; Humans; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Sex Factors; Time Factors | 1984 |
Hormonal effects of apomorphine in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Apomorphine; Chronic Disease; Estradiol; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormones, Anterior; Prolactin; Schizophrenia | 1984 |
The prolactin response in schizophrenic, schizophreniform, and manic disorders.
Topics: Apomorphine; Bipolar Disorder; Female; Humans; Male; Prolactin; Psychotic Disorders; Schizophrenia | 1984 |
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophrenia.
Topics: Apomorphine; Erythrocytes; Growth Hormone; Humans; Lithium; Lithium Carbonate; Prognosis; Radioimmunoassay; Schizophrenia | 1982 |
Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
Topics: Adult; Apomorphine; Blood Platelets; Female; Growth Hormone; Humans; Hypothalamus; Male; Monoamine Oxidase; Receptors, Dopamine; Schizophrenia | 1983 |
Dopamine D1 receptors in human parathyroid gland: in vitro and in vivo studies.
Topics: Adult; Apomorphine; Flupenthixol; Humans; Male; Metoclopramide; Parathyroid Glands; Parathyroid Hormone; Prolactin; Receptors, Dopamine; Schizophrenia; Thioxanthenes | 1983 |
[Various aspects of the interaction between the dopamine and opiate systems in schizophrenia].
Topics: Apomorphine; Dopamine; Humans; Naloxone; Schizophrenia | 1982 |
[Apomorphine in dyskinesia and psychomotor agitation].
Topics: Adolescent; Adult; Apomorphine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Movement Disorders; Psychomotor Agitation; Schizophrenia | 1982 |
Conditioned dopaminergic activity.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Conditioning, Classical; Cues; Dextroamphetamine; Dopamine; Homovanillic Acid; Humans; Male; Motor Activity; Rats; Receptors, Dopamine; Schizophrenia; Substance-Related Disorders | 1982 |
Hormones, dopamine receptors and schizophrenia.
Topics: Acute Disease; Apomorphine; Chronic Disease; Dopamine; Dopamine Antagonists; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Prolactin; Receptors, Dopamine; Reference Values; Schizophrenia | 1981 |
Receptor supersensitivity: relationships to cerebral anatomy and histopathology of schizophrenia.
Topics: Afferent Pathways; Apomorphine; Brain; Corpus Striatum; Gliosis; Haloperidol; Humans; Receptors, Dopamine; Schizophrenia; Spiperone | 1981 |
Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia.
Topics: Adult; Apomorphine; Cerebrovascular Circulation; Cognition; Dopamine; Dopamine Agonists; Gyrus Cinguli; Humans; Male; Schizophrenia; Tomography, Emission-Computed | 1995 |
Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Butyrophenones; Dogs; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; In Vitro Techniques; Isoxazoles; Lysergic Acid Diethylamide; Motor Activity; Neostriatum; Oxygen Consumption; Piperidines; Rats; Risperidone; Schizophrenia; Serotonin Antagonists; Species Specificity; Tryptamines | 1994 |
Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Apomorphine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Startle; Schizophrenia; Tetrahydronaphthalenes | 1995 |
Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findings.
Topics: Adult; Analysis of Variance; Apomorphine; Clozapine; Growth Hormone; Humans; Male; Prolactin; Schizophrenia; Schizophrenic Psychology | 1995 |
Predictors of response to clozapine.
Topics: Adult; Age Factors; Age of Onset; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Clozapine; Female; Growth Hormone; Humans; Male; Probability; Prolactin; Schizophrenia; Schizophrenic Psychology; Sex Factors; Treatment Outcome | 1994 |
The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Arousal; Brain Mapping; Dextroamphetamine; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Hippocampus; Male; Motor Activity; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior | 1993 |
Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Electric Stimulation; Electroencephalography; Habituation, Psychophysiologic; Haloperidol; Limbic System; Male; Models, Neurological; Motor Activity; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Salicylamides; Schizophrenia; Seizures; Stereotyped Behavior; Tegmentum Mesencephali; Time Factors | 1993 |
Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates.
Topics: Adolescent; Adult; Apomorphine; Biomarkers; Brain; Cohort Studies; Dopamine; Eye Movements; Female; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index | 1993 |
Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Schizophrenia | 1996 |
Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents.
Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dopamine; gamma-Aminobutyric Acid; Muscimol; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Thalamus | 1995 |
Phospholipase A2 and the hypofrontality hypothesis of schizophrenia.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine Agonists; Female; Injections, Intraventricular; Male; Phospholipases A; Phospholipases A2; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rats, Wistar; Schizophrenia; Substantia Nigra | 1996 |
Prefrontal cortical and hippocampal modulation of dopamine-mediated effects.
Topics: Aging; Amphetamine; Animals; Animals, Newborn; Apomorphine; Disease Models, Animal; Dopamine; Haloperidol; Hippocampus; Humans; Motor Activity; Prefrontal Cortex; Rats; Reflex, Startle; Schizophrenia; Sexual Maturation; Stereotyped Behavior; Stress, Psychological; Synapses; Synaptic Transmission | 1998 |
Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating.
Topics: Amphetamine; Analysis of Variance; Animals; Apomorphine; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Male; N-Methylaspartate; Oxytocin; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 1999 |
Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Locomotion; Male; Neural Inhibition; Prefrontal Cortex; Rats; Rats, Wistar; Schizophrenia | 1999 |
Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats.
Topics: Age Factors; Animals; Apomorphine; Dose-Response Relationship, Drug; Female; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2000 |
Who believes in "communication"? The Norman Cousins Lecture, 1999.
Topics: Adaptation, Psychological; Aggression; Animals; Apomorphine; Arthritis, Rheumatoid; Autoimmune Diseases; Behavior; Behavior, Animal; beta-Adrenergic Receptor Kinases; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Humans; Hypothalamo-Hypophyseal System; Inflammation; Motor Activity; Multiple Sclerosis; Neuroimmunomodulation; Neurosecretory Systems; Pituitary-Adrenal System; Psychoneuroimmunology; Psychotherapy; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta-2; Schizophrenia; Stress, Physiological; Th1 Cells; Th2 Cells; Trichinellosis | 2000 |
Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia.
Topics: Age Factors; Amphetamine; Animals; Apomorphine; Asphyxia Neonatorum; Behavior, Animal; Cesarean Section; Disease Models, Animal; Dopamine; Female; Guinea Pigs; Humans; Hypoxia, Brain; Infant, Newborn; Male; Motor Activity; Neural Inhibition; Reflex, Startle; Schizophrenia | 2000 |
Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy.
Topics: Adult; Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Subcutaneous; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizophrenia; Trihexyphenidyl | 2001 |
The role of endogenous cortisol in neuroendocrine studies.
Topics: Apomorphine; Dopamine Agonists; Humans; Hydrocortisone; Neurosecretory Systems; Schizophrenia | 2002 |
Facilitation of dopamine-mediated locomotor activity in adult rats following cholinergic denervation.
Topics: Aging; Animals; Apomorphine; Behavior, Animal; Cerebellum; Cerebral Cortex; Cholinergic Fibers; Denervation; Dextroamphetamine; Dopamine; Dopamine Agents; Female; Hippocampus; Immunohistochemistry; Immunotoxins; Injections, Intraventricular; Maze Learning; Motor Activity; Parahippocampal Gyrus; Rats; Rats, Sprague-Dawley; Schizophrenia | 2002 |
Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man.
Topics: Adolescent; Adult; Antipsychotic Agents; Apomorphine; Bipolar Disorder; Drug Interactions; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Schizophrenia; Sulpiride | 1977 |
Neuroendocrine and amine studies in affective illness.
Topics: Affective Symptoms; Anti-Anxiety Agents; Apomorphine; Biogenic Amines; Blood Glucose; Female; Growth Hormone; Humans; Insulin; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Schizophrenia | 1977 |
Evaluation of naloxone in laboratory tests predictive of clinical antipsychotic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Clozapine; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Naloxone; Rats; Schizophrenia; Species Specificity; Stereotyped Behavior | 1977 |
[Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
Topics: Acute Disease; Amphetamines; Antipsychotic Agents; Apomorphine; Blood Platelets; Bromocriptine; Disulfiram; Dopamine; Dopamine beta-Hydroxylase; Humans; Male; Monoamine Oxidase; Neurons; Phenelzine; Psychotropic Drugs; Schizophrenia; Tranylcypromine | 1978 |
Endorphins, dopamine, and schizophrenia.
Topics: Antipsychotic Agents; Apomorphine; Brain; Brain Chemistry; Chemical Phenomena; Chemistry; Cyclic AMP; Dopamine; Endorphins; Humans; Kainic Acid; Membrane Proteins; Narcotic Antagonists; Nerve Tissue Proteins; Phosphoproteins; Receptors, Dopamine; Receptors, Opioid; Schizophrenia; Synaptic Transmission | 1979 |
Dopamine and schizophrenia.
Topics: Apomorphine; Dyskinesia, Drug-Induced; Humans; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1976 |
Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
Topics: Apomorphine; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levallorphan; Male; Naloxone; Prolactin; Receptors, Dopamine; Schizophrenia | 1979 |
Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
Topics: Adult; Apomorphine; Clozapine; Dibenzazepines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia | 1979 |
Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research.
Topics: Adult; Apomorphine; Cyproheptadine; Growth Hormone; Haloperidol; Humans; Male; Pituitary Gland, Anterior; Prolactin; Receptors, Dopamine; Schizophrenia | 1979 |
Neuroendocrine studies with dopamine agonists in schizophrenia.
Topics: Adult; Apomorphine; Growth Hormone; Humans; Levodopa; Male; Receptors, Dopamine; Schizophrenia | 1978 |
Suppression of prolactin by dopamine agonists in schizophrenics and controls.
Topics: Adult; Apomorphine; Chronic Disease; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Schizophrenia | 1978 |
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.
Topics: Adult; Aged; Apomorphine; Brain; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Female; Haloperidol; Humans; Male; Middle Aged; Nucleus Accumbens; Putamen; Schizophrenia; Spiperone; Tranquilizing Agents | 1978 |
Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.
Topics: Adult; Apomorphine; Growth Hormone; Humans; Levodopa; Male; Receptors, Dopamine; Schizophrenia | 1976 |
Dopaminergic function in two patients with catalepsy.
Topics: Adult; Amobarbital; Apomorphine; Catalepsy; Female; Growth Hormone; Humans; Injections, Intravenous; Injections, Subcutaneous; Receptors, Dopamine; Schizophrenia; Sodium Chloride | 1977 |
Postsynaptic supersensitivity in schizophrenia.
Topics: Acute Disease; Adenylyl Cyclases; Adolescent; Adult; Apomorphine; Blood Platelets; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prostaglandins E; Receptors, Dopamine; Schizophrenia | 1977 |
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia | 1977 |
Evidence for dopamine receptors in the human brain mediating sedation and sleep.
Topics: Adult; Apomorphine; Brain; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Receptors, Dopamine; Schizophrenia; Sleep | 1977 |
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia | 1977 |
Neuroendocrine assessment of dopaminergic activity in schizophrenia.
Topics: Adult; Apomorphine; Dopamine; Growth Hormone; Humans; Levodopa; Male; Schizophrenia | 1977 |
A neuroendocrine study of supersensitivity in tardive dyskinesia.
Topics: Adult; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1977 |
Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
Topics: Adult; Aged; Apomorphine; Dyskinesia, Drug-Induced; Growth Hormone; Humans; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Time Factors; Tranquilizing Agents | 1976 |
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders | 1975 |
Clinical studies with dopamine-receptor stimulants.
Topics: Adult; Apomorphine; Blood Pressure; Dopamine; Female; Hallucinations; Humans; Male; Metoclopramide; Middle Aged; Piperazines; Piribedil; Receptors, Drug; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Stimulation, Chemical; Vomiting | 1975 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents | 1975 |
Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics.
Topics: Adult; Apomorphine; Arginine Vasopressin; Dopamine; Growth Hormone; Humans; Male; Neurophysins; Oxytocin; Pituitary Gland, Posterior; Reference Values; Schizophrenia; Schizophrenic Psychology | 1992 |
Mesolimbic deficits exacerbate amphetamine treatment. Clinical implications for drug abusers.
Topics: Amphetamines; Animals; Apomorphine; Behavior, Animal; Globus Pallidus; Humans; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders; Time Factors | 1992 |
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
Topics: Adult; Aged; Apomorphine; Brain; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Neurologic Examination; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1992 |
Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cholecystokinin; Dopamine; Male; Mesencephalon; Neurons; Pyrazoles; Rats; Rats, Inbred Strains; Schizophrenia | 1991 |
An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia.
Topics: Age Factors; Animals; Apomorphine; Catalepsy; Estradiol; Female; Haloperidol; Male; Rats; Receptors, Dopamine; Schizophrenia; Sex Factors; Testosterone | 1991 |
Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
Topics: Adolescent; Adult; Apomorphine; Blood Glucose; Brain; Cerebral Cortex; Corpus Striatum; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Neural Pathways; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed | 1991 |
Working in psychiatric research: answers tomorrow, dilemmas today.
Topics: Adolescent; Apomorphine; Clinical Protocols; Countertransference; Drug Therapy, Combination; Humans; Male; Methylphenidate; Nursing Staff, Hospital; Research; Schizophrenia | 1991 |
Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Topics: Analysis of Variance; Animals; Apomorphine; Benzazepines; Clozapine; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle; Salicylamides; Schizophrenia; Spiperone | 1991 |
Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
Topics: Adult; Apomorphine; Brain; Cerebral Ventricles; Chronic Disease; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Schizophrenia; Secretory Rate | 1986 |
Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
Topics: Animals; Anorexia Nervosa; Antipsychotic Agents; Apomorphine; Brain; Cholecystokinin; Glutamine; Humans; Mesencephalon; Neurons; Proglumide; Receptors, Dopamine; Schizophrenia | 1985 |
Down-regulation of central dopamine receptors in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Apomorphine; Female; Growth Hormone; Homovanillic Acid; Humans; Male; Radioimmunoassay; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Stimulation, Chemical | 1985 |
Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
Topics: Adult; Antipsychotic Agents; Apomorphine; Growth Hormone; Homovanillic Acid; Humans; Male; Prolactin; Receptors, Dopamine; Schizophrenia | 1985 |
Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Male; Phenothiazines; Pimozide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reinforcement Schedule; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1986 |
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine.
Topics: Adolescent; Adult; Antipsychotic Agents; Apomorphine; Brain; Dopamine; Growth Hormone; Humans; Middle Aged; Schizophrenia; Schizophrenia, Catatonic; Schizophrenia, Paranoid | 1986 |
Novel drug treatments for schizophrenia.
Topics: Adrenergic Agonists; Antipsychotic Agents; Apomorphine; Bromocriptine; Humans; Neuropeptides; Receptors, Dopamine; Schizophrenia | 1987 |
[Behavioral pharmacological investigation and clinical consideration of the inhibitory potencies of psychotropic drugs against the D-1 and D-2 dopamine receptors].
Topics: Animals; Apomorphine; Corpus Striatum; Male; Psychotropic Drugs; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Stereotyped Behavior | 1986 |
Longitudinal growth hormone studies in schizophrenia.
Topics: Adult; Apomorphine; Body Weight; Feeding Behavior; Female; Growth Hormone; Humans; Longitudinal Studies; Male; Recurrence; Schizophrenia; Seasons; Time Factors | 1988 |
Growth hormone response to apomorphine and family patterns of illness.
Topics: Adolescent; Adult; Aged; Antisocial Personality Disorder; Apomorphine; Genetic Markers; Growth Hormone; Humans; Middle Aged; Pituitary Gland, Anterior; Psychotic Disorders; Schizophrenia; Schizotypal Personality Disorder | 1987 |
Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning.
Topics: Adolescent; Adult; Apomorphine; Female; Growth Hormone; Humans; Male; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sexual Behavior; Social Behavior | 1987 |
Growth hormone response to apomorphine and diagnosis: a comparison of three diagnostic systems.
Topics: Adult; Apomorphine; Bipolar Disorder; Female; Growth Hormone; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia | 1986 |
Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients.
Topics: Adolescent; Adult; Age Factors; Apomorphine; Dopamine; Female; Growth Hormone; Hospitalization; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Dopamine agonists in the treatment of schizophrenia.
Topics: Apomorphine; Dopamine Antagonists; Humans; Receptors, Dopamine; Schizophrenia | 1986 |
Growth hormone response to apomorphine.
Topics: Apomorphine; Diagnosis, Differential; Female; Growth Hormone; Humans; Male; Psychotic Disorders; Schizophrenia | 1987 |
Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
Topics: Adult; Apomorphine; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Topics: Apomorphine; Bromocriptine; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Metoclopramide; Monitoring, Physiologic; Neurosecretory Systems; Prolactin; Receptors, Dopamine; Schizophrenia; Selegiline; Time Factors | 1985 |
Are there state-dependent markers in schizophrenia?
Topics: Amphetamine; Apomorphine; Growth Hormone; Humans; Norepinephrine; Schizophrenia | 1985 |
Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients.
Topics: Adult; Apomorphine; Haloperidol; Humans; Male; Movement Disorders; Schizophrenia | 1972 |
Neuropsychopharmacology of monoamines and their regulatory enzymes.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Biogenic Amines; Brain; Cocaine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dopamine beta-Hydroxylase; Humans; Isoenzymes; Methylphenidate; Monoamine Oxidase; Neurons; Norepinephrine; Phenylethanolamine N-Methyltransferase; Schizophrenia; Serotonin; Tyrosine; Tyrosine 3-Monooxygenase | 1974 |
Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
Topics: Adrenal Cortex Hormones; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Catecholamines; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine; Dopamine beta-Hydroxylase; Enzyme Inhibitors; Humans; Limbic System; Motor Activity; Neurons; Norepinephrine; Rats; Receptors, Drug; Schizophrenia; Self Stimulation; Tranquilizing Agents; Tyrosine 3-Monooxygenase | 1974 |
[Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
Topics: Animals; Apomorphine; Arousal; Caudate Nucleus; Chlorpromazine; Chlorprothixene; Electroencephalography; Fluphenazine; Haloperidol; Humans; Methotrimeprazine; Perphenazine; Phenothiazines; Promazine; Rats; Reflex; Schizophrenia; Thioridazine; Tranquilizing Agents | 1969 |
[Therapy of schizophrenia with neuroleptics from the pharmacologic viewpoint].
Topics: Animals; Apomorphine; Catatonia; Cats; Dopamine; Humans; Psychopharmacology; Rats; Schizophrenia; Tranquilizing Agents | 1969 |